Quality of life / Argentina / Treatment Outcome / Public Health / Risk assessment / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs
Research Design / Quality of life / Treatment Outcome / First Aid / Prospective studies / Humans / Human Resources for Health / Hospitalization / Sample Size / Cardiopulmonary Resuscitation / Institutionalization / Adult / Public health systems and services research / Cost Benefit Analysis / Volunteers / Economic evaluation / Cost of Illness / Defibrillators / Humans / Human Resources for Health / Hospitalization / Sample Size / Cardiopulmonary Resuscitation / Institutionalization / Adult / Public health systems and services research / Cost Benefit Analysis / Volunteers / Economic evaluation / Cost of Illness / Defibrillators
Primary Care / Primary Health Care / Public Health / Quality Control / Spain / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record
Primary Care / Primary Health Care / Public Health / Quality Control / Spain / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record
Spain / Stroke / Humans / Female / Atrial Fibrillation / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles / Anticoagulants / Aged / Middle Aged / Budgets / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Benzimidazoles
Tropical Medicine / Tropical medicine (Health Sciences) / Humans / Animals / Palpation / Public health systems and services research / Cost Benefit Analysis / Sensitivity and Specificity / Health Care Costs / Democratic Republic of the Congo / Lymph nodes / Public health systems and services research / Cost Benefit Analysis / Sensitivity and Specificity / Health Care Costs / Democratic Republic of the Congo / Lymph nodes
China / Public Health / Humans / Female / Male / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American
Program Evaluation / Primary Health Care / Evaluation / Developing Countries / Brazil / Health / Pregnancy / Humans / Female / Newborn Infant / Family Health / Public health systems and services research / Cost Benefit Analysis / Perinatal mortality / Prenatal Care / Health / Pregnancy / Humans / Female / Newborn Infant / Family Health / Public health systems and services research / Cost Benefit Analysis / Perinatal mortality / Prenatal Care